- Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis
-
Chung GE, Kim D
- KMID: 1776798
- Clin Mol Hepatol.
- 2013 Jun;19(2):116-119.
- doi: 10.3350/cmh.2013.19.2.116
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- beta-catenin activated hepatocellular adenoma
-
Chu HH, Moon WS
- KMID: 1776807
- Clin Mol Hepatol.
- 2013 Jun;19(2):185-189.
- doi: 10.3350/cmh.2013.19.2.185
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer
-
Jeong WK, Choi SY, Kim J
- KMID: 1776808
- Clin Mol Hepatol.
- 2013 Jun;19(2):190-194.
- doi: 10.3350/cmh.2013.19.2.190
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The lymphatic vascular system in liver diseases: its role in ascites formation
-
Chung C, Iwakiri Y
- KMID: 1776796
- Clin Mol Hepatol.
- 2013 Jun;19(2):99-104.
- doi: 10.3350/cmh.2013.19.2.99
The lymphatic system is part of the circulatory system and plays a key role in normal vascular function. Its failure plays a crucial role in the development and maintenance of... -
- CITED
-
- Close
- SHARE
-
- Close
- Important predictor of mortality in patients with end-stage liver disease
-
Kim HJ, Lee HW
- KMID: 1776797
- Clin Mol Hepatol.
- 2013 Jun;19(2):105-115.
- doi: 10.3350/cmh.2013.19.2.105
Prognosis is an essential part of the baseline assessment of any disease. For predicting prognosis of end-stage liver disease, many prognostic models were proposed. Child-Pugh score has been the reference... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease
-
Lee HJ, Oh MJ
- KMID: 1776806
- Clin Mol Hepatol.
- 2013 Jun;19(2):179-184.
- doi: 10.3350/cmh.2013.19.2.179
Variceal bleeding and hepatorenal syndrome (HRS) are serious and life-threatening complications of advanced liver disease. Terlipressin is widely used to manage both acute variceal bleeding and HRS due to its... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients
-
Lee HS, Kweon YO, Tak WY, Park SY, Kang EJ, Lee YL, Yang HM, Park HW
- KMID: 1776802
- Clin Mol Hepatol.
- 2013 Jun;19(2):148-155.
- doi: 10.3350/cmh.2013.19.2.148
BACKGROUND/AIMS: Chronic hepatitis C patients with advanced fibrosis have unsatisfactory sustained virological response (SVR) rates. Few data demonstrating the efficacy of combination therapy in chronic hepatitis C patients with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma
-
Ahn JS, Jeon JR, Yoo HS, Park TK, Park CK, Sinn DH, Paik SW
- KMID: 1776805
- Clin Mol Hepatol.
- 2013 Jun;19(2):173-178.
- doi: 10.3350/cmh.2013.19.2.173
Hepatoid adenocarcinoma (HAC) is a rare type of extrahepatic carcinoma whose morphology is similar to that of hepatocellular carcinoma (HCC). Metachronous HCC and HAC in the same patient is extremely... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of entecavir plus carnitine complex (GODEX(R)) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study
-
Jun DW, Kim BI, Cho YK, Kim HJ, Kwon YO, Park SY, Han SY, Baek YH, Jung YJ, Kim HY, Kim W, Heo J, Woo HY, Hwang SG, Rim KS, Choi JY, Bae SH, Lee YS, Lim YS, Cheong JY, Cho SW, Lee BS, Kim SH, Sohn JH, Kim TY, Paik YH, Kim JK, Lee KS
- KMID: 1776804
- Clin Mol Hepatol.
- 2013 Jun;19(2):165-172.
- doi: 10.3350/cmh.2013.19.2.165
BACKGROUND/AIMS: Carnitine and vitamin complex (Godex(R)) is widely used in patients with chronic liver disease who show elevated liver enzyme in South Korea. The purpose of this study is to... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis
-
Tsung PC, Ryu SH, Cha IH, Cho HW, Kim JN, Kim YS, Moon JS
- KMID: 1776800
- Clin Mol Hepatol.
- 2013 Jun;19(2):131-139.
- doi: 10.3350/cmh.2013.19.2.131
BACKGROUND/AIMS: Spontaneous bacterial peritonitis (SBP) has been known to greatly influence the survival rate of patients with liver cirrhosis. However, the factors that affect the survival rate in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis
-
Chung JH, Ahn HS, Kim SG, Lee YN, Kim YS, Jeong SW, Jang JY, Lee SH, Kim HS, Kim BS
- KMID: 1776803
- Clin Mol Hepatol.
- 2013 Jun;19(2):156-164.
- doi: 10.3350/cmh.2013.19.2.156
BACKGROUND/AIMS: Several noninvasive methods have recently been developed for the evaluation of liver fibrosis. The accuracy of transient elastography (TE), acoustic-radiation-force impulse (ARFI) elastography, and real-time elastography (RTE) in predicting... -
- CITED
-
- Close
- SHARE
-
- Close
- The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults
-
Ju DY, Choe YG, Cho YK, Shin DS, Yoo SH, Yim SH, Lee JY, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI
- KMID: 1776801
- Clin Mol Hepatol.
- 2013 Jun;19(2):140-147.
- doi: 10.3350/cmh.2013.19.2.140
BACKGROUND/AIMS: Waist circumference (WC) is a risk factor for metabolic syndrome and is related to insulin resistance (IR) and nonalcoholic fatty liver disease (NAFLD). The purpose of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
-
Kim YS, Jung ES, Hur W, Bae SH, Choi JY, Song MJ, Kim CW, Jo SH, Lee CD, Lee YS, Choi SW, Yang JM, Jang JW, Kim SG, Jung SW, Kim HK, Chae HB, Yoon SK
- KMID: 1776799
- Clin Mol Hepatol.
- 2013 Jun;19(2):120-130.
- doi: 10.3350/cmh.2013.19.2.120
BACKGROUND/AIMS: The aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver disease (NAFLD), and (2)... -
- CITED
-
- Close
- SHARE
-
- Close
